Literature DB >> 34745310

Efficacy and Safety of Chinese Medicine in Treating Arrhythmia: Meta-Analysis of Randomized Controlled Trials.

Hanyu He1, Guoning Han2, Xinju Li1, Hongyi Lan1, Ying Li2, Xiaoxin Dou1, Yi Guo1, Mingxing Zhang3, Hongyan Liu1.   

Abstract

OBJECTIVE: To evaluate the clinical efficacy of traditional Chinese medicine in the treatment of arrhythmia.
METHODS: The researchers searched CNKI, VIP, WF, PubMed, Web of Science, and Cochrane Library with the set-up themes as randomized controlled trials (RCTs) on the clinical efficacy of traditional Chinese medicine in the treatment of arrhythmia. This research evaluated all the retrieve literature and conducted selection based on the evaluation. Stata software was applied for meta-analysis.
RESULTS: 23 articles were retrieved with a total patient number of 2846. The results observed from the meta-analysis indicated the following: (1) compared with the result showed in placebo group, the traditional Chinese medicine group presented to have good efficacy, especially in the treatment of premature ventricular contractions. (2) In comparison with the western medicine group, the curative effect of Chinese medicine could approximately equal the therapeutic effect as western medicine. (3) Compared with the application of sole western medicine group, the combination of both traditional Chinese medicine and western medicine could have a better curative effect.
CONCLUSION: In the treatment of arrhythmia disease, the application of traditional Chinese medicine can be considered as an effective method. In addition to that, the therapeutic effect obtained from the combination of both Chinese traditional medicine and western medicine is clinically better than that of the sole use of western medicine.
Copyright © 2021 Hanyu He et al.

Entities:  

Year:  2021        PMID: 34745310      PMCID: PMC8570860          DOI: 10.1155/2021/9960471

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  2 in total

1.  [Network Meta-analysis of randomized controlled trials of Chinese patent medicine for bradyarrhythmia].

Authors:  Hai-Yin Hu; Zhao-Chen Ji; Dan-Dan Yu; Feng-Wen Yang; Hui Wang; Wen-Ke Zheng; Jun-Hua Zhang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2020-03

2.  Chinese medicine shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial.

Authors:  Yunfang Liu; Ning Li; Zhenhua Jia; Feng Lu; Jielin Pu
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-16       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.